MINDACORP.NSE logo

MINDACORP.NSE
Minda Corporation Ltd

224
Loading...
Loading...
News
all
press releases
CM Yogi visits hydrogen facility in Japan’s Yamanashi, highlights UP’s vision
TOKYO: Uttar Pradesh Chief Minister Yogi Adityanath visited a hydrogen facility in Yamanashi Prefecture, Japan, reaffirming the state's resolve to push forward green hydrogen initiatives and sustainable energy solutions as part of its long-term development strategy. During his visit to the East Asian nation, the Chief Minister also interacted with members of the Indian diaspora while travelling onward to Yamanashi. He received a warm welcome from the community, reflecting strong engagement between Uttar Pradesh and overseas Indians. Sharing details of his visit in a post on X, CM Yogi said, "Visited the Yamanashi Hydrogen Facility in Yamanashi Prefecture, Japan, and witnessed the advanced Power-to-Gas system in operation. Appreciated the pioneering work being undertaken in green hydrogen and clean energy technologies. Yamanashi's innovative approach offers valuable insights for accelerating sustainable energy transition and clean mobility solutions." He further stated that Uttar Pradesh is "firmly committed to advancing green hydrogen, sustainable energy solutions and a future driven by innovation, self-reliance and environmental responsibility." The visit comes alongside a major investment development for Uttar Pradesh, as Memorandums of Understanding (MoUs) worth nearly Rs 11,000 crore were signed with leading Japanese companies.
cityfalcon.com·1mo ago
News Placeholder
More News
News Placeholder
₹11,000 crore Japanese boost to UP: CM Yogi seals mega industrial investment deals in Tokyo
Uttar Pradesh Chief Minister Yogi Adityanath’s visit to Japan has secured Memoranda of Understanding worth ₹11,000 crore with leading Japanese firms including Kubota Corporation, Minda Corporation, Japan Aviation Electronics Industry, Nagase & Co., Ltd., Seiko Advance, and others.Officials say the visit marks a significant step in deepening India–Japan economic ties and accelerating Uttar Pradesh’s manufacturing and infrastructure expansion.
cityfalcon.com·1mo ago
News Placeholder
Minda Corp eyes tripling exports from India, Indonesia and Vietnam
… plans to triple exports from India, Indonesia , and Vietnam in five years. Executive … other Asian countries as well to the US," he added. India … has not been edited by Asianet Newsable English staff and is …
cityfalcon.com·2mo ago
News Placeholder
“Our focus for next five years is to triple exports from India and our plants in Indonesia, Vietnam”: Minda Corporation’s Aakash Minda
Minda Corporation Ltd is supplying auto components to almost all automotive manufacturers in the country and its focus is to triple exports in the next five years from India and plant locations in Indonesia and Vietnam, the company's Executive Director Aakash Minda said on Thursday.
cityfalcon.com·2mo ago
News Placeholder
Brief India: Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD and more
In this briefing: Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD Q3FY26 - Consolidated Earnings Preview Minda Corporation Ltd- Forensic Analysis 1. Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD We attended Somany Ceramics' analyst meet, represented by Mr Abhishek Somany (MD and CEO), Mr Sailesh Kedawat (CFO), and Mr Ameya Somany (KMP – son of MD) Management indicated that demand is showing signs of recovery Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below. 2. Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag The India Pharma and Healthcare sector is expected to see moderate revenue growth as EBITDA margins remain flat We project sales/EBITDA growth of 11%/10% YoY for our coverage universe Our assumptions are: (1) Pharma coverage will see 10% YoY sales growth driven by 11% YoY increase in the India business Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.
cityfalcon.com·3mo ago
<
...
1
>

Latest MINDACORP.NSE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.